Elite Pharmaceuticals, Inc. (ELTP)
0.2891
-0.01
(-2.00%)
USD |
OTCM |
Aug 24, 16:00
Elite Pharmaceuticals Max Drawdown (5Y) : 87.92% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 87.92% |
| June 30, 2026 | 87.92% |
| May 31, 2026 | 87.92% |
| April 30, 2026 | 87.92% |
| March 31, 2026 | 87.92% |
| February 28, 2026 | 87.92% |
| January 31, 2026 | 87.92% |
| December 31, 2025 | 87.92% |
| November 30, 2025 | 87.92% |
| October 31, 2025 | 87.92% |
| September 30, 2025 | 87.92% |
| August 31, 2025 | 87.92% |
| July 31, 2025 | 87.92% |
| June 30, 2025 | 87.92% |
| May 31, 2025 | 87.92% |
| April 30, 2025 | 87.92% |
| March 31, 2025 | 87.92% |
| February 28, 2025 | 87.92% |
| January 31, 2025 | 87.92% |
| December 31, 2024 | 87.92% |
| November 30, 2024 | 87.92% |
| October 31, 2024 | 87.92% |
| September 30, 2024 | 87.92% |
| August 31, 2024 | 87.92% |
| July 31, 2024 | 89.83% |
| Date | Value |
|---|---|
| June 30, 2024 | 89.83% |
| May 31, 2024 | 90.56% |
| April 30, 2024 | 90.56% |
| March 31, 2024 | 90.56% |
| February 29, 2024 | 90.56% |
| January 31, 2024 | 91.47% |
| December 31, 2023 | 92.01% |
| November 30, 2023 | 92.16% |
| October 31, 2023 | 92.16% |
| September 30, 2023 | 92.16% |
| August 31, 2023 | 92.16% |
| July 31, 2023 | 92.16% |
| June 30, 2023 | 92.16% |
| May 31, 2023 | 92.16% |
| April 30, 2023 | 92.16% |
| March 31, 2023 | 92.16% |
| February 28, 2023 | 92.16% |
| January 31, 2023 | 92.16% |
| December 31, 2022 | 92.16% |
| November 30, 2022 | 92.16% |
| October 31, 2022 | 92.16% |
| September 30, 2022 | 92.16% |
| August 31, 2022 | 92.16% |
| July 31, 2022 | 92.16% |
| June 30, 2022 | 92.16% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Nektar Therapeutics | 99.39% |
| Daré Bioscience, Inc. | 95.72% |
| Eton Pharmaceuticals, Inc. | 79.94% |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 43.89 |
| Beta (5Y) | 0.4008 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 82.66% |
| Historical Sharpe Ratio (5Y) | 0.5755 |
| Historical Sortino (5Y) | 2.148 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 18.31% |